Publications
Résultats 391 à 400 sur 563 Publications
| Titre | Auteurs | Année | Revue |
|---|---|---|---|
| A Rationally Designed Humanized Antibody Selective for Amyloid Beta Oligomers in Alzheimer’s Disease. | Gibbs, E., Silverman, JM.**, Zhao, B., Peng, X., Wang, J., Wellington, CL.**, Mackenzie, IR.**, Plotkin, SS.**, Kaplan, JM., Cashman, NR**. | 2019 | Scientific reports. |
| International Parkinson’s Disease Genomics C. Parkinson’s disease age at onset genome-wide association study: Defining heritability, genetic loci, and alpha-synuclein mechanisms. | "Blauwendraat, C., Heilbron, K., Vallerga, CL., Bandres-Ciga, S., von Coelln, R., Pihlstrom, L., Simon-Sanchez, J., Schulte, C., Sharma, M., Krohn, L.*, Siitonen, A., Iwaki, H., Leonard, H., Noyce, AJ., Tan, M., Gibbs, JR., Hernandez, DG., Scholz, SW., Jankovic, J., Shulman, LM., Lesage, S., Corvol, JC., Brice, A., van Hilten, JJ., Marinus, J., Eerola-Rautio J., Tienari P., Majamaa K., Toft M., Grosset DG., Gasser, T., Heutink, P., Shulman, JM., Wood, N., Hardy, J., Morris, HR., Hinds, DA., Gratten, J., Visscher, PM., Gan-Or, Z.**, Nalls, MA., Singleton, AB. " | 2019 | Mov Disord |
| Detection of Active Caspase-3 in Mouse Models of Stroke and Alzheimer’s Disease with a Novel Dual Positron Emission Tomography/Fluorescent Tracer | Ostapchenko, VG., Snir, J., Suchy, M., Fan, J., Cobb, MR., Chronik, BA., Kovacs, M., Prado, VF.**, Hudson, RHE., Pasternak, SH.**, Prado, MAM.**, Bartha, R.** | 2019 | Contrast Media Mol Imaging. |
| Impact of the Quebec Alzheimer Plan on the detection and management of Alzheimer disease and other neurocognitive disorders in primary health care: a retrospective study. | Vedel, I.**, Sourial, N.*, Arsenault-Lapierre, G.*, Godard-Sebillotte, C.*, Bergman, H.** | 2019 | CMAJ Open |
| Impact of health service interventions on acute hospital use in community-dwelling persons with dementia: A systematic literature review and meta-analysis. | Godard-Sebillotte, C.*, Le Berre, M.*, Schuster, T., Trottier, M., Vedel, I**. | 2019 | PLoS One. |
| SMPD1 mutations, activity, and alpha-synuclein accumulation in Parkinson’s disease. | Alcalay, R.N., Mallett, V., Vanderperre, B., Tavassoly, O., Dauvilliers, Y., Wu, R.Y.J., Ruskey, J.A., Leblond, C.S., Ambalavanan, A., Laurent, S.B., Spiegelman, D., Dionne-Laporte, A., Liong, C., Levy, O.A., Fahn, S., Waters, C., Kuo, S.H., Chung, W.K., Ford, B., Marder, K.S., Kang, U.J., Hassin-Baer, S., Greenbaum, L., Trempe, J.F., Wolf, P., Oliva, P., Zhang, X.K., Clark, L.N., Langlois, M., Dion, P.A., Fon, E.A.**, Dupre, N.**, Rouleau, G.A.**, Gan-Or, Z**. | 2019 | Movement Disorders. |
| A highly predictive signature of cognition and brain atrophy for progression to Alzheimer’s dementia. | Tam, A.*, Dansereau, C.**, Iturria-Medina, Y.**, Urchs, S., Orban, P., Sharmarke, H., Breitner, J.**, Bellec, P**. | 2019 | "Alzheimer's Disease Neuroimaging I. GigaScience. " |
| Rationale and design of the ENGAGE study : a double-blind randomized controlled preference trial using a comprehensive cohort design to measure the effect of a cognitive and leisure-based intervention in older adults with a memory complaint. | Belleville, S.**, Moussard, A.*, Ansaldo, A.I.**, Belchior, P.**, Bherer, L.**, Bier, N., Bohbot, V.D.**, Bruneau, M.A.**, Cuddy, L.L.**, Gilbert, B., Jokel, R.**, Mahalingam, K.*, McGilton, K.**, Murphy, K.J.**, Naglie, G.**, Rochon, E.**, Troyer, A.K.**, Anderson, N.D.**. | 2019 | Trials |
| Abeta-induced vulnerability propagates via the brain’s default mode network. | Pascoal, T.A.*, Mathotaarachchi, S.*, Kang, M.S., Mohaddes, S., Shin, M.*, Park, A.Y., Parent, M.J.*, Benedet, A.L.*, Chamoun, M., Therriault, J., Hwang, H., Cuello, A.C.**, Misic, B., Soucy, J.P.**, Aston, J.A.D., Gauthier, S.**, Rosa-Neto, P** | 2019 | Nature communications. |
| Solvent Composition Effects on the Structural Properties of the Abeta42 Monomer from the 3D-RISM-KH Molecular Theory of Solvation. | Blinov, N., Wishart, DS**, Kovalenko, A**. | 2019 | The journal of physical chemistry |
Résultats 391 à 400 sur 563 Publications